GHK-Cu Field Guide
Field Guide / Copper Peptide Research

GHK-Cu: fifty years of copper peptide research, plainly explained and fully cited.

A color-coded field guide to what the peer-reviewed literature has measured — collagen synthesis, hair follicle activation, gene-expression modulation, and more.

Start with the research Jump to references
Skin Hair Mechanism Dosage FAQ References
Flat illustration of a smiling copper atom with orbiting teal electrons beside a coiled collagen spring and a sprouting gold hair follicle on a bright blue ground
~4,000 Genes Modulated
55.8% Wrinkle Reduction vs Control
71.5 New Hairs (6-mo RCT)
340.38 Molecular Weight Da

What Is GHK-Cu and What Does the Research Show?

GHK-Cu — glycyl-L-histidyl-L-lysine copper(II) complex — is a tripeptide that forms naturally in human plasma, saliva, and urine. It is the copper-chelated form of the free tripeptide GHK, and that copper coordination is essential: the copper-free form shows significantly reduced potency in fibroblast assays.[1] Molecular weight 401.91 Da, CAS 89030-95-5, INCI name Copper Tripeptide-1.

The compound's research history begins with Loren Pickart's 1973 discovery that human serum promoted liver tissue regeneration in culture; the active fraction turned out to be GHK-Cu. Over the following five decades, more than 50 peer-reviewed publications have characterized its behavior across dermal fibroblast cultures, rodent wound models, hair follicle systems, lung tissue, skeletal muscle, and the gut epithelium.

At its core, GHK-Cu acts as a copper chaperone — concentrating bioavailable Cu(II) at wound sites and cell surfaces. From there it activates multiple repair pathways simultaneously: TGF-beta receptor upregulation, Nrf2/Keap1 antioxidant defense, NF-kappaB anti-inflammatory suppression, Wnt/beta-catenin hair follicle signaling, and SIRT1-dependent metabolic protection.[4]

This field guide organizes the literature into six chapters: skin-collagen research (teal), hair-follicle research (gold), mechanism and gene expression (blue), dosage and chemistry (orange), safety and FAQ (magenta), and references (green). Every quantitative claim cites the study that measured it.

GHK vs GHK-Cu: The Role of Copper Chelation

Definition

GHK is the free tripeptide — glycyl-L-histidyl-L-lysine (MW 340.38 Da). GHK-Cu is the copper(II) chelate (MW 401.91 Da), where Cu(II) is coordinated via the histidine imidazole nitrogen, the glycine alpha-amino nitrogen, and the deprotonated glycine-histidine amide nitrogen in a 1:1 molar complex.

GHK is the free tripeptide — glycyl-L-histidyl-L-lysine (MW 340.38 Da). GHK-Cu is the copper(II) chelate of the same sequence. The two are related but not interchangeable.

Copper coordination happens via the histidine imidazole nitrogen, the glycine alpha-amino nitrogen, and the deprotonated glycine-histidine amide nitrogen, forming a stable 1:1 molar complex. That coordination geometry is what enables the biological activities documented in the literature.[1] In direct fibroblast-culture comparisons, copper-free GHK has significantly reduced potency in collagen synthesis assays.

The distinction matters when reading the literature: some studies use GHK (the free peptide, often in gene-expression databases), while others use GHK-Cu (the chelated form, used in most topical cosmetic and injectable research). The GHK-Cu copper peptide research section flags which form each study used.

GHK-Cu Copper Peptide: Research-Documented Benefits

The peer-reviewed record across five decades documents GHK-Cu effects in six domains:

Skin & Collagen

Collagen & Matrix Remodeling

Stimulated collagen synthesis in human dermal fibroblast cultures at picomolar to nanomolar concentrations — stimulation began at 10⁻¹² M, maximized at 10⁻⁹ M, independent of cell proliferation.[1] Upregulation extends beyond type I collagen to types III and IV, elastin, and glycosaminoglycans.[5]

Gene Expression

Gene Expression Modulation

Microarray analysis found GHK modulated approximately 31.2% of human genes (4,278 with ≥50% expression change) — 59% upregulated, 41% downregulated. Ubiquitin-proteasome: 41 genes up, 1 down. DNA repair: 47 up, 5 down.[2]

Hair Research

Hair Follicle Activation

A randomized double-blind 6-month trial in 45 males with androgenetic alopecia found a GHK peptide complex significantly increased hair count by 52.6–71.5 hairs vs 9.6 in placebo (p<0.05) with no adverse events.[6]

Skin & Wrinkles

Wrinkle & Elasticity Improvement

GHK-Cu in a nanocarrier formulation reduced facial wrinkle volume by 55.8% vs untreated control (p<0.001) and wrinkle depth by 32.8% (p=0.012) in human volunteers.[18]

Systemic Research

Lung & Systemic Protection

GHK-Cu at 0.2–20 μg/g/day IP attenuated cigarette-smoke-induced emphysema in mice by activating the Nrf2/Keap1 antioxidant pathway and reducing TNF-alpha and IL-1beta.[9]

Anti-Aging

Age-Related Decline

Plasma GHK drops from approximately 200 ng/mL at age 20 to under 80 ng/mL by age 60 — a more than 60% reduction.[3] In aged mouse fibroblasts, GHK reduced senescence markers p21 and p53 and restored migration capacity.[11]

For GHK-Cu skin collagen research and copper peptide hair growth studies, the dedicated chapter pages go deeper on each domain.

Why Does GHK-Cu Decline With Age?

GHK is not synthesized by cells as a standalone product — it is released by injury-activated proteinases hydrolyzing the alpha2(I) chain of type I collagen. When tissue is damaged, local collagen breakdown liberates GHK as a local wound-response signal. At the systemic level, plasma GHK peaks around 10⁻⁷ M (approximately 200 ng/mL) in young adults and declines to under 80 ng/mL by age 60, a reduction of more than 60%.[3]

In human COPD patients, plasma GHK was significantly lower (70.27 ± 38.87 ng/mL) than in healthy controls (133.0 ± 54.54 ng/mL) and correlated positively with skeletal muscle mass and the antioxidant enzyme SOD2.[10] The age-related depletion of an endogenous tissue-repair signal has motivated research into whether exogenous GHK-Cu can restore its downstream effects.

See the GHK-Cu mechanism of action section for pathway detail.

The Anti-Aging Research Case for GHK-Cu

The evidence base for GHK-Cu in aging biology is stronger than most cosmetic peptides: more than 50 peer-reviewed publications, a well-characterized mechanism, documented human-trial results in collagen synthesis and wrinkle depth, and recent work in cognitive aging and skeletal muscle preservation.

In aging mice given intranasal GHK-Cu (15 mg/kg/day for 8 weeks), spatial working memory and navigation learning improved significantly; neuroinflammation marker MCP-1 decreased and axonal damage marker NFL-1 was reduced in both sexes.[15] A 2024 study in aged mouse fibroblasts showed GHK reversed the myofibroblast senescence phenotype via integrin-beta1 signaling, restoring the cellular capacity for tissue resolution.[11]

Research Limitation

The primary limitation acknowledged across the literature: most studies are rodent models or small-scale human trials, several are industry-sponsored, and independent replication of Pickart's broader gene-expression claims remains limited. The research case is compelling; it is also not complete. This field guide documents what has been measured, and names the gaps.